FDA regulatory considerations for oncology drug development.
Saved in:
| Title: | FDA regulatory considerations for oncology drug development. |
|---|---|
| Authors: | Moon, Hanlim1 hanlim.moon@medirama.co.kr, Zang, Dae Young2, Ryu, Min‐Hee3, Seo, YeonSook1, Oh, Bitna1, Hwang, Sunjin1, Farrand, Lee1,4 |
| Source: | Pharmacology Research & Perspectives. Aug2024, Vol. 12 Issue 4, p1-4. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 179046786 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: FDA regulatory considerations for oncology drug development. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Moon%2C+Hanlim%22">Moon, Hanlim</searchLink><relatesTo>1</relatesTo><i> hanlim.moon@medirama.co.kr</i><br /><searchLink fieldCode="AR" term="%22Zang%2C+Dae+Young%22">Zang, Dae Young</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Ryu%2C+Min‐Hee%22">Ryu, Min‐Hee</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Seo%2C+YeonSook%22">Seo, YeonSook</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Oh%2C+Bitna%22">Oh, Bitna</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Hwang%2C+Sunjin%22">Hwang, Sunjin</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Farrand%2C+Lee%22">Farrand, Lee</searchLink><relatesTo>1,4</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Pharmacology+Research+%26+Perspectives%22">Pharmacology Research & Perspectives</searchLink>. Aug2024, Vol. 12 Issue 4, p1-4. 4p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179046786 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/prp2.1254 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 4 StartPage: 1 Titles: – TitleFull: FDA regulatory considerations for oncology drug development. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Moon, Hanlim – PersonEntity: Name: NameFull: Zang, Dae Young – PersonEntity: Name: NameFull: Ryu, Min‐Hee – PersonEntity: Name: NameFull: Seo, YeonSook – PersonEntity: Name: NameFull: Oh, Bitna – PersonEntity: Name: NameFull: Hwang, Sunjin – PersonEntity: Name: NameFull: Farrand, Lee IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: Aug2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 20521707 Numbering: – Type: volume Value: 12 – Type: issue Value: 4 Titles: – TitleFull: Pharmacology Research & Perspectives Type: main |
| ResultId | 1 |